Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MXCT - MaxCyte appoints new chief scientific officer

MXCT - MaxCyte appoints new chief scientific officer

MaxCyte Inc.
On Wednesday, life sciences company, MaxCyte (NASDAQ:MXCT) announced the appointment of Dr. Cenk Sumen as its new Chief Scientific Officer. Prior to his appointment, Sumen served Stemson Therapeutics as the Chief Technology Officer, and before that, he has worked for companies including Thermo Fisher Scientific (TMO) and Hitachi Chemical Advanced Therapeutics Solutions. In July, the London-listed MaxCyte (MXCT) made its public debut in the U.S. on the Nasdaq stock exchange. The IPO valued the firm at up to $1.3 billion. The company has partnered with Allogene Therapeutics (NASDAQ:ALLO) for allogeneic CAR T therapies based on its MaxCyte platform. In January, ahead of Q4 2021 results scheduled for March. 22, MaxCyte (MXCT) set its Q4 and 2021 projections above the consensus.

For further details see:

MaxCyte appoints new chief scientific officer
Stock Information
Company Name: MaxCyte Inc.
Stock Symbol: MXCT
Market: NASDAQ
Website: maxcyte.com
Menu
MXCT MXCT Quote MXCT Short MXCT News MXCT Articles MXCT Message Board
Get MXCT Alerts

News, Short Squeeze, Breakout and More Instantly...